Amarin Corp Plc (AMRN)

[sts66]

Incidentally, if the Reduce-it studies are anywhere near as good as they were in the Jellis study, they will be reported out early and then there will be no BO at all.

Are you kidding me? If those results are excellent BP will be jumping over each other to get in line to bid for AMRN! If we're not bought out before then, of course, which I fully expect if sales ramp as expected - anybody on Lovaza should be switched to Vasecapa, almost malpractice to keep them on L when V is available.